The Lancet Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology is dedicated to providing a global, authoritative, and independent forum for high impact clinical research and opinion covering all aspects of endocrinology, diabetes, metabolism, obesity, osteoporosis, bone metabolism, as well as thyroid, lipid, and adrenal disorders. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, the journal delivers essential research, expert review, and candid commentary to provide context and perspective on important advances shaping these fields today.
The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on www.thelancet.com before appearing in print.
Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Review, and Personal Views. Visit http://ees.elsevier.com/thelancetde to learn more about our editorial scope and aims and to submit your manuscript.
Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.To find out more about The Lancet Diabetes & Endocrinology, visit www.thelancet.com/diabetes-endocrinology.
Editor-in-Chief Sarah Linklater
- Imprint: ELSEVIER
- ISSN: 2213-8587